CompletedNCT00854737
Official study titleA Combination of Cytidine and Omega-3 Fatty Acids in Bipolar Disorder: Are There Additive or Synergistic Mood Stabilizing Effects?
This study has finished and is no longer accepting participants.
Multiple locations, including BelmontBipolarityPlacebo comparisonAges 18–55
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
TerminatedNCT02623504
What is this study about?Researchers are comparing Carbamazepine and placebo, tracking side effects to assess long-term safety in children and adolescents with bipolarity type I.
This study ended early.
Multiple locations, including OrlandoBipolarityMedication studyAges 10–17
- Countries
- United States
- Sponsor
- Validus Pharmaceuticals
WithdrawnNCT01372722
Official study titlePhase I Study of Bilateral DBS to the Nucleus Accumbens (NAcc-DBS) for Treatment Resistant Bipolar Disorder
This study was withdrawn before enrollment.
In BonnBipolarityDevice studyAges 20–70
- Countries
- Germany
- Sponsor
- University Hospital, Bonn
CompletedNCT01670123
Official study titleDevelopment of a Personalized Real-time Intervention for Bipolar Disorder
This study has finished and is no longer accepting participants.
In La JollaBipolarityBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- University of California, San Diego
CompletedNCT02272010
Official study titleTargeted Alterations in n-3 and n-6 Fatty Acids for the Management of Mood Variability in the Maintenance Phase of Bipolar Disorder
This study has finished and is no longer accepting participants.
In HersheyBipolarityInterventional studyAges 18–100
- Countries
- United States
- Sponsor
- Milton S. Hershey Medical Center
CompletedNCT03127176
Official study titleDysbiosis in Bipolar Disorder: MicrObiota Bipolar Study
This study has finished and is no longer accepting participants.
In BarcelonaBipolarityObservational studyAges 18–55
- Countries
- Spain
- Sponsor
- Hospital Clinic of Barcelona
CompletedNCT00943085
Official study titleFamily-Focused Therapy as Early Treatment for Youth at Risk for Bipolar Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including StanfordBipolarityBehavioural studyAges 9–17
- Countries
- United States
- Sponsor
- University of California, Los Angeles
CompletedNCT02456896
Official study titleEffect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
This study has finished and is no longer accepting participants.
In BhubaneswarBipolarityMedication studyAges 18–45
- Countries
- India
- Sponsor
- All India Institute of Medical Sciences, Bhubaneswar